Next Quarterly Earnings
Date confirmed from the company's own financial calendar.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
BRAIN Biotech AG, a leading German company, develops and markets innovative enzyme and microorganism solutions for diverse industrial applications. Focusing on sustainable biotechnology and customized biocatalysts, BRAIN Biotech optimizes production processes in sectors such as nutrition, health, and environment.
Date confirmed from the company's own financial calendar.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
BRAIN Biotech is scheduled to report its next quarterly earnings on 08/27/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
BRAIN Biotech last reported quarterly earnings on 5/28/2026 (Q1 2026). Earnings per share (EPS) came in at -0.29 EUR.
Across its last 3 earnings reports, BRAIN Biotech stock moved by ±13.9% on average the following day. The largest reaction was +30.1% on 02/25/2026; 2 of 3 reactions were positive.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Past price reactions are not a reliable indicator of future performance.